“PHARMACEUTİCAL DRUG ADDICTION” AND SUSTAİNABLE DEVELOPMENT: THE ROLE OF PHARMACEUTİCAL INSTİTUTİONS

Abstract

This article examines the phenomenon of “pharmaceutical drug addiction” as a complex socio-medical issue that undermines the resilience of the healthcare system and impedes progress toward the Sustainable Development Goals, particularly in the context of public health (SDG 3) and institutional effectiveness (SDG 16). Special attention is given to the role of pharmaceutical institutions—not as the source of the problem, but as potential partners in addressing the consequences of the uncontrolled circulation of prescription drugs. Based on an analysis of the regulatory framework in the Kyrgyz Republic, expert opinions, and existing practices, the article proposes recommendations to improve pharmaceutical regulation, prevent addictive behavior, and strengthen institutional resilience in the healthcare sector